Sunshine Biopharma Inc. (SBFM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 9,410,230 | 8,901,341 | 8,435,178 | 9,303,067 |
| Cost of sales | 5,987,364 | 6,170,915 | 5,569,027 | 6,946,810 |
| Gross profit | 3,422,866 | 2,730,426 | 2,866,151 | 2,356,257 |
| Taxes | - | - | - | 145,805 |
| Office | - | - | - | 713,245 |
| Consulting | - | - | - | 54,048 |
| Salaries | 2,048,676 | 1,525,446 | 2,093,850 | 1,556,176 |
| R&d | 196,232 | 215,277 | 126,362 | 436,235 |
| Accounting | 75,611 | 293,759 | 124,772 | 88,394 |
| Consulting | 736,727 | 365,287 | 475,032 | - |
| Office | 806,605 | 925,878 | 530,334 | - |
| Director fees | 100,000 | 100,000 | 100,000 | 100,000 |
| Marketing | 201,658 | 398,361 | 282,745 | 256,325 |
| Legal | 64,995 | 27,199 | 118,311 | 223,436 |
| Impairment of intangible assets | 1,061,809 | - | - | - |
| Depreciation | 72,533 | 64,793 | 64,627 | 50,870 |
| Taxes | 112,675 | 110,176 | 56,471 | - |
| Total general & administrative expenses | 5,477,521 | 4,026,176 | 3,972,504 | 3,624,533 |
| (loss) from operations | -2,054,655 | -1,295,750 | -1,106,353 | -1,268,276 |
| Interest income | 72,715 | 75,367 | 108,614 | 143,995 |
| Interest expense | - | - | - | 245 |
| Foreign exchange gain | 1,940 | 451 | 15,153 | 286,535 |
| Total other income (expense) | 74,655 | 75,818 | 123,767 | 430,285 |
| Net (loss) before income taxes | -1,980,000 | -1,219,932 | -982,586 | -837,991 |
| Provision for income taxes | -209,166 | -40,161 | 215,217 | -343,691 |
| Net (loss) | -1,770,834 | -1,179,771 | -1,197,803 | -494,300 |
| Gain (loss) from foreign exchange translation | 1,084,557 | - | 851,640 | -835,450 |
| Comprehensive (loss) | -686,277 | -1,179,771 | -346,163 | -1,329,750 |
| Basic (loss) per common share | -0.39 | -0.44 | -0.94 | -9.94 |
| Earnings per share, diluted | -0.82 | -0.44 | - | - |
| Weighted average common shares outstanding (basic ) | 4,496,108 | 2,703,293 | 1,267,565 | 49,726 |
| Weighted average number of shares outstanding, diluted | 3,604,653 | 2,703,293 | 1,267,565 | 49,726 |